Anonymous16 days ago
The American College of Cardiology and American Heart Association released their first major cholesterol management update in eight years on March 13, 2026, lowering the recommended age for statin consideration from 40 to 30, restoring specific LDL cholesterol targets, mandating universal lipoprotein(a) testing, and deploying a new race-free risk calculator based on 6.5 million patients. The guidelines represent a fundamental shift toward earlier, more aggressive prevention of cardiovascular disease, though critics note the lack of randomized trial data specifically validating statin use in younger, lower-risk populations.